Signals, Powered By EquityPandit
Gufic Biosciences’s board has provided its approval to the Scheme of Amalgamation of Gufic Stridden Bio-Pharma with the company.
Gufic Biosciences has said in a BSE filing that “The board of directors of the company has approved the Scheme of Amalgamation of Gufic Stridden Bio-Pharma Pvt Ltd with the company, subject to the necessary approvals.”
It further said that the transaction is a related party transaction.
Gufic Biosciences has said that “Post merger, the shareholders of the company would be issued shares of the transferee company based on the valuation report from independent chartered accountant.”
